Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2002
10/30/2002EP0775126B1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
10/30/2002CN1377347A 药学活性磺酰胺衍生物 Pharmaceutically active sulfonamide derivatives
10/30/2002CN1377346A Z-pyrazoline-5-ones
10/30/2002CN1377336A Carboxylic acid derivatives and drugs containing the same
10/30/2002CN1377269A Vitronectin receptor antagonists
10/30/2002CN1377268A Cell adhesion inhibitors
10/30/2002CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002US6472536 Such as 2-(4-(4-cyclopentyloxybenzyl)phenyl)amino-imidazoline; antinociceptive agents; ip receptor antagonists; treating inflammatory pain
10/29/2002US6472529 Viricides
10/29/2002US6472526 Shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in pharmaceutical composition and intermediates
10/29/2002US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002US6472404 HIV protease inhibitors
10/29/2002US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002US6472394 MCH antagonists and their use in the treatment of obesity
10/29/2002US6472392 Triazole compounds and the use thereof as dopamine-D3 -ligands
10/29/2002US6472391 Nitrogen-containing heterocyclic compounds
10/29/2002US6472388 Psychotherapeutic agents.
10/29/2002US6472387 Methods of using compounds as neuro-protective agents
10/29/2002US6472386 Cyclic diamine compound with 5-membered ring groups
10/29/2002US6472349 Pyridine-2,3-dicarboxylic acid diamides
10/29/2002US6472348 Pyridone derivatives and herbicides
10/29/2002CA2342471C Heterocyclecarbonylmethyl amine intermediates
10/29/2002CA2236553C Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
10/24/2002WO2002083863A2 Thiazole and other heterocyclic ligands and use thereof
10/24/2002WO2002083668A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002WO2002083665A1 DIHYDRO-BENZO[b][1,4]DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I
10/24/2002WO2002083664A1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002WO2002083663A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
10/24/2002WO2002083662A2 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds
10/24/2002WO2002083657A2 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
10/24/2002WO2002083656A2 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments
10/24/2002WO2002083654A1 Triazinyl amide derivatives as angiogenesis inhibitors
10/24/2002WO2002083652A1 DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
10/24/2002WO2002083642A1 Compounds useful as anti-inflammatory agents
10/24/2002WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002WO2002083143A1 Cxcr3 antagonists
10/24/2002WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002WO2002066035A3 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/24/2002WO2002050065A3 Pyrazole compounds useful as protein kinase inhibitors
10/24/2002US20020156289 Synthesis of epothilones
10/24/2002US20020156283 Psychological disorders; side effect reduction
10/24/2002US20020156115 Pyrazolylacetic acid derivatives
10/24/2002US20020156110 Anticancer, antiproliferative and antiarthritic agents
10/24/2002US20020156105 Tri-aryl-substituted-ethane PDE4 inhibitors
10/24/2002US20020156102 Piperidine amides as modulators of chemo kine receptor activity
10/24/2002US20020156089 Use of CRF antagonists and related compositions
10/24/2002US20020156074 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors
10/24/2002US20020156071 Tricyclic biphenyl sulfonamide matrix metalloproteinase inhibitors
10/24/2002US20020156069 Benzo thiadiazine matrix metalloproteinase inhibitors
10/24/2002US20020156063 Heterocyclic amide compounds useful for treating diseases associated with activity of cathepsin K
10/24/2002US20020156018 Treating parasitic diseases, which are mediated by such proteases. In particular, treating malaria by inhibiting the cysteine protease falcipain.
10/24/2002DE10148598A1 New N-(acylaminophenyl)-heteroaryl-benzenesulfonamide derivatives, useful as antiviral agents, especially effective against human cytomegalovirus infections
10/24/2002DE10119423A1 New cyanoimino- or nitroimino-substituted azole derivatives or analogs, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents
10/24/2002DE10108481A1 Pyridylpyrimidine Pyridylpyrimidines
10/24/2002CA2490819A1 Compounds useful as anti-inflammatory agents
10/24/2002CA2444596A1 Large conductance calcium-activated k channel opener
10/24/2002CA2443697A1 1,4-disubstituted benzo-fused compounds
10/24/2002CA2443487A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002CA2443366A1 Triazinyl amide derivatives as angiogenesis inhibitors
10/24/2002CA2443234A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002CA2431553A1 Cxcr3 antagonists
10/23/2002EP1251128A1 Cyclohexylamine derivatives as subtype selective N-methyl-D-aspartate antagonists
10/23/2002EP1251127A1 Novel sidechain-bearing taxanes and intermediates thereof
10/23/2002EP1250337A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
10/23/2002EP1250336A1 Piperidine derivatives and their use as serotonin receptor antagonists
10/23/2002EP1250332A1 Inhibitors of interleukin 5 gene expression
10/23/2002EP1250328A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
10/23/2002EP1196384A4 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
10/23/2002EP1073642B1 The use of dihydropyrimidines as medicaments, and novel substances for the treatment of hepatitis b
10/23/2002EP0979229B1 2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors
10/23/2002EP0894089B1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
10/23/2002EP0783499B1 Benzofuran derivatives as tachykinin antagonists
10/23/2002EP0767170B1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/23/2002CN1376153A Amide compounds
10/23/2002CN1376150A Drug compositions exhibiting thrombo poietin agonism
10/23/2002CN1376149A 2,4-diamino-1,3,5-triazine, method for the production and use of the same as herbicides and plant growth regulators
10/23/2002CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002CN1093123C Aralkyl and aralkylidene heterocyclic lactams and imides
10/22/2002US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002US6469167 Improved process for the preparation of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl) thiazolidine-2,4-dione
10/22/2002US6469047 Tyrosine derivatives
10/22/2002US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002US6469037 Prophylactic or therapeutic drug for renal diseases
10/22/2002US6469036 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/22/2002US6469032 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
10/22/2002US6469025 For the prophylaxis or treatment of a disease or disorder in a mammal in which the extravasation of leukocytes plays a role; inhibiting the binding of alpha 4 integrins to their ligands
10/22/2002US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002US6469011 Benzenesulfonamide compounds useful as TXA2 and 5-HT2 receptor antagonists
10/22/2002US6469006 Particularly for treating hiv infections
10/22/2002US6469003 Pyridazinone derivatives
10/22/2002US6469001 IL-5 inhibiting 6-azauracil derivatives
10/22/2002US6468977 Compounds useful in treatment treatment of disorder and/or disease caused by activity of enzymes such as human rhinovirus 3c protease, transglutaminase and cathepsins
10/17/2002WO2002081478A2 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
10/17/2002WO2002081470A1 Oxazolidinones containing a sulfonimid group as antibiotics
10/17/2002WO2002081469A1 Oxazolidinone-sulfoximines and -sulfilimines as antibiotics
10/17/2002WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002WO2002081449A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/17/2002WO2002081448A1 Benzamidine derivative
1 ... 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 ... 628